Health Alert:

Joslin is following the events with regard to the Coronavirus (2019-nCoV). For the health and safety of our patients, visitors, and staff we are following recommendations of the Massachusetts Department of Public Health and the Centers for Disease Control. Those agencies are reporting a low risk for people in the United States to contract Coronavirus but encourage these prevention practices.

Alert Close

Dayna McGill, MD, is a Pediatric Endocrinologist in the Pediatric, Adolescent, and Young Adult Section and a Research Associate in the Section of Clinical, Behavioral, and Outcomes Research, as well as an Instructor of Pediatrics at Harvard Medical School. Dr. McGill received her medical degree from New York Medical College, followed by residency training in general pediatrics at the Children’s Hospital of Philadelphia (CHOP) and sub-specialty fellowship training in pediatric endocrinology at the Massachusetts General Hospital and Joslin Diabetes Center.

Dr. McGill sees children, teens, and young adults with diabetes at Joslin and her clinical interests include pediatric diabetes and general pediatric endocrinology. Her goal is to meet each family where they are, and determine together how we can optimize diabetes management in the context of their everyday life, family priorities, and technology preferences. She also has interest and experience in the diagnosis, treatment and management of other endocrine disorders including growth problems, early or delayed puberty, thyroid disorders, and more.

Dr. McGill’s research focuses on the design, implementation, and evaluation of interventions to improve health care delivery and outcomes for young persons with type 1 diabetes (T1D). She has presented her work at national research meetings for the American Diabetes Association (ADA) and the Pediatric Endocrine Society (PES).

Georgetown University

Medical School
New York Medical College

Children's Hospital of Philadelphia

Massachusetts General Hospital, Joslin Diabetes Center

  • Pediatric
  • Type 1
  • Type 2

Dr. McGill is interested in telehealth interventions to engage teens and young adults with T1D in more frequent contact, more meaningful interactions with their diabetes team, and improve their uptake and continued use of current diabetes technologies.

Contact Information

Office Phone

(617) 732-2603